Publication | Open Access
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
61
Citations
22
References
2016
Year
Phase Ib StudyHepatologyMedicinePharmacologyPathologyLiver CancerCancer TreatmentOncologyHepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
| Year | Citations | |
|---|---|---|
Page 1
Page 1